We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.86M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.7M
3
CNR
Core Natural Resources Inc
CNR
+$8.26M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$6.63M
5
ORCL icon
Oracle
ORCL
+$6.25M

Top Sells

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$14M
2
HTLF
Heartland Financial USA, Inc.
HTLF
+$11.1M
3
NVDA icon
NVIDIA
NVDA
+$9.36M
4
AMZN icon
Amazon
AMZN
+$8.75M
5
NFLX icon
Netflix
NFLX
+$8.58M

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IKT icon
1126
Inhibikase Therapeutics
IKT
$386M
$24.3K ﹤0.01%
+11,098
New +$27.9K
KOPN icon
1127
Kopin
KOPN
$780M
$24.1K ﹤0.01%
+25,800
New +$37.9K
SGMO
1128
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$22.5K ﹤0.01%
+34,382
New +$36.4K
ITRG
1129
Integra Resources
ITRG
$535M
$21.5K ﹤0.01%
+17,361
New +$18.9K
VUZI icon
1130
Vuzix
VUZI
$217M
$21.5K ﹤0.01%
+10,526
New +$34.5K
KEEL
1131
Keel Infrastructure Corp
KEEL
$2.05B
$19K ﹤0.01%
24,156
-27,000
-53% -$35.8K
WHWK
1132
Whitehawk Therapeutics
WHWK
$259M
$18.2K ﹤0.01%
10,197
-2,700
-21% -$7.05K
ACRS icon
1133
Aclaris Therapeutics
ACRS
$868M
$18K ﹤0.01%
11,791
-94,560
-89% -$202K
CRBU icon
1134
Caribou Biosciences
CRBU
$165M
$17.5K ﹤0.01%
19,166
-15,810
-45% -$20.5K
TLRY icon
1135
Tilray
TLRY
$602M
$15.7K ﹤0.01%
2,390
– –
ABAT icon
1136
American Battery Technology Co
ABAT
$361M
$14.7K ﹤0.01%
+14,279
New +$19.4K
ORGN
1137
DELISTED
Origin Materials
ORGN
$13.4K ﹤0.01%
+673
New +$18.5K
ONDS icon
1138
Ondas Inc
ONDS
$5.31B
$11.8K ﹤0.01%
+11,006
New +$16.5K
BDSX icon
1139
Biodesix
BDSX
$262M
$7.32K ﹤0.01%
+585
New +$11.2K
LONA
1140
LeonaBio Inc
LONA
$70.5M
$3.13K ﹤0.01%
1,100
– –
PSNYW icon
1141
Polestar Automotive Holding ADS Class C-1
PSNYW
$372M
$2.98K ﹤0.01%
551
– –
SRZNW icon
1142
Surrozen Inc Warrant
SRZNW
$8.86K
$738 ﹤0.01%
24,614
– –
KPLTW
1143
DELISTED
Katapult Holdings Warrant
KPLTW
$255 ﹤0.01%
28,680
– –
AAOI icon
1144
Applied Optoelectronics
AAOI
$11.2B
– –
-189,348
Closed -$6.98M
ABOS icon
1145
Acumen Pharmaceuticals
ABOS
$176M
– –
-48,414
Closed -$83.3K
ABNB icon
1146
PUT
Airbnb
ABNB
$111B
– –
-3,100
Closed -$407K
ACEL icon
1147
Accel Entertainment
ACEL
$978M
– –
-23,465
Closed -$251K
ACHC icon
1148
Acadia Healthcare
ACHC
$2.96B
– –
-15,270
Closed -$605K
ACHR icon
1149
CALL
Archer Aviation
ACHR
$4.78B
– –
-62,400
Closed -$608K
ACI icon
1150
CALL
Albertsons Companies
ACI
$5.89B
– –
-51,200
Closed -$1.01M
44 45
46
47 48

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.